Skip to main content

MoneyWorks4Me

Wanbury’s API facility at Andhra Pradesh clears cGMP inspection by South Korea MFDS

20 Nov 2026 Evaluate

Wanbury’s API manufacturing facility at Tanuku, Andhra Pradesh, has successfully completed a three-day cGMP inspection conducted by the Ministry of Food and Drug Safety (MFDS), Republic of Korea, with zero observations. This achievement follows the successful completion of a South Korea MFDS cGMP inspection at the company’s Patalganga manufacturing facility in April 2026, which was also concluded with zero observations.

Wanbury, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 Companies’ in India (as per ORG-IMS), has a strong presence in API global market and domestic branded Formulation.

Peers
Company Name CMP
Sun Pharma. Inds. 1885.10
Dr. Reddys Labs. 1390.50
Cipla 1414.95
Lupin 2010.00
Zydus Lifesciences 1195.05
View more..